Skip to content
Search

Latest Stories

Pharmacy businesses need to keep up with Gen Z expectations around payments, suggests new report

Pharmacy businesses need to keep up with Gen Z expectations around payments, suggests new report

Almost 30 per cent of Gen Z would prefer to pay online when purchasing health and wellbeing services or products, compared to less than six per cent of the Silent Generation 

A new study has underscored the significance of offering customers a variety of payment choices, particularly as digital platforms gain popularity among younger age groups.


Almost one in three (30 per cent) people surveyed by payments solutions provider, Access PaySuite reported a negative experience when purchasing health and wellbeing products or services due to limited payment options.

The research showed that online and in-person cash payments were the most preferred modes of payment, while more than a quarter of consumers expressed their preference for paying through Direct Debit.

About 17 per cent of the participants favoured using a mobile app for payments during the booking process, followed by mobile in-person options like Google Pay (14 per cent) and phone-based transactions using debit or credit card) (13 per cent).

Expectedly, generational differences were seen in the choice of payment methods. Almost 30 per cent of respondents belonging to Generation Z (those born between 1997–2010) said they would rather pay online, compared to less than 6 per cent of the Silent Generation (those born between 1928–1945).

Hence, the study report emphasised that pharmacy businesses need to make “significant changes to their business operations” to meet the expectations of Gen Z.

Andrea Dunlop, managing director of Access PaySuite, commented: “It’s no surprise that the ongoing economic difficulties consumers are facing means that many are already weighing up the affordability of health and wellbeing treatments or products.

“Households are having to make difficult choices about where they spend their increasingly stretched disposable income.

“Our findings highlight the challenges facing businesses in the pharmacy sector and businesses need to keep up with consumer expectations around payments.

“For businesses that can have a transformative impact on the day-to-day lives of their customers, it’s even more important to remove barriers to sale,” he said.

He added that consumers expect a range of convenient payment options that suit their needs while stressing the fact that online and mobile payments have become essential for daily operations, particularly for those younger demographics.

Statistics from UK Finance showed that three in ten adults are registered for mobile payments, compared to 54 per cent and 48 per cent for 16-24 and 25-34-year-olds respectively.

Open Banking UK data also indicated that 10 per cent of British consumers are active users of open banking, with Gen Z being a significant demographic contributing to this adoption.

Broader research conducted by TransUnion revealed that 42 per cent of Gen Z have used open banking services.

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less